Canine Arthritis Treatment Market Share

Report ID: 2972
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Regionally, the canine arthritis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America industry is set to dominate majority revenue share by 2037, on the back of high pet population, in the U.S. which raised the demand for arthritis treatment for canines. Moreover, according to the American Pet Product Association, the national pet products industry exceeded USD 100 billion in 2020. This is anticipated to boost the regional market growth.

The market in the Asia Pacific region is estimated to witness highest CAGR over the forecast period on the back of increasing number of NGOs working for animal welfare, along with increasing population of pets. China has the highest dog population in Asia Pacific region, with over 25 million dogs, followed by Japan with 12 million, Philippines with more than 11.5 million, and India with around 10 million pet dogs, as of 2019. This is estimated to boost the market growth in the region.

Browse key industry insights with market data tables & charts from the report:

Canine Arthritis Treatment Market Size & Share, Growth Forecasts 2037

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of canine arthritis treatment is evaluated at USD 2.66 billion.

Canine Arthritis Treatment Market size was over USD 2.56 billion in 2024 and is poised to exceed USD 4.59 billion by 2037, growing at over 4.6% CAGR during the forecast period i.e., between 2025-2037.

North America industry is set to dominate majority revenue share by 2037, on the back of high pet population, in the U.S.

The major players in the market are Boehringer Ingelheim USA Corporation, Norbrook Laboratories Limited, American Regent, Inc., Vetoquinol S.A., Ceva SantÃ© Animale, Elanco Animal Health Inc., Hill's Pet Nutrition, Inc., and others.